Barriers to and facilitators of antiretroviral therapy adherence in Nepal: A qualitative study

Journal of Health, Population and Nutrition

Volumn 30, Issue 4, 2012, Pages 410-419

  Wasti, Sharada P ^a   Simkhada, Padam ^a   Randall, Julian ^b   Freeman, Jennifer V ^a   Van Teijlingen, Edwin ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c BOURNEMOUTH UNIVERSITY   (United Kingdom)

Author keywords

Adherence; Antiretroviral drugs; Barriers; Facilitators; HIV AIDS; South Asia

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; FEE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOTIVATION; NEPAL; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SOCIAL STIGMA; SOCIAL SUPPORT; VERBAL COMMUNICATION;

ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MOTIVATION; NARRATION; NEPAL; PRESCRIPTION FEES; QUALITATIVE RESEARCH; SOCIAL STIGMA; SOCIAL SUPPORT;

MLCS; MLOWN;

EID: 84873136370     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F et al.; ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-29.
2. Wasti SP, Simkhada P, Teijlingen ER. Antiretroviral treatment programmes in Nepal: problems and barriers. Kathmandu Univ Med J (KUMf) 2009; 7:306-14.
3. United Nations General Assembly Special Session. UNGASS country progress report: Nepal. Kathmandu: National Centre for AIDS & STD Control, 2010. 78 p.
4. Wasti SP, Simkhada P, Randall J, van Teijlingen E. Issues and challenges of HIV/AIDS prevention and treatment programme in Nepal. Global J Health Sci 2009; 1:62-72.
5. Konkle-Parker DJ, Erlen JA, Dubbert PM. Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care 2008; 19:98-104.
6. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav 2010; 14:778-84.
7. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
8. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42:200-9.
9. Wang X, Wu Z. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China. AIDS 2007; 21(Suppl 8):S149-55.
10. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3:e438.
11. Hardon A, Davey S, Gerrits T, Hodgkin C, Irunde H, Kgatlwane J et al. From access to adherence: the challenges of antiretroviral treatment - studies from Botswana, Tanzania and Uganda 2006. Geneva: World Health Organization, 2006. 301 p.
12. Wasti SP, van Teijlingen E, Simkhada P, Randall J, Baxter S, Kirkpatrick P et al. Factors influencing adherence to antiretroviral treatment in Asian developing countries: a systematic review. Trop Med Int Health 2012; 17:71-81.
13. Weiner B. A theory of motivation for some classroom experiences. J Educ Psychol 1979; 71:3-25.
14. Dahal DR. Social composition of the population: caste/ethnicity and religion in Nepal. In: Population monograph of Nepal 2003. Vol. 1. Chapter 3. Kathmandu: Central Bureau of Statistics, National Planning Commission Secretariat, Government of Nepal, 2003:87-135.
15. Schein EH. Defining organizational culture. Classics Organ Theor 1985; 3:490-502.
16. Geertz C. The interpretation of cultures: selected essays. New York, NY: Basic Books, 1973:3-30.
17. Randall J. Managing change/changing managers. London: Taylor & Francis, 2004:105-28.
18. Meek VL. Organizational culture: origins and weaknesses. Organ Stud 1988; 9:453-73.
19. nd ed. London: Sage Publications, 2003:1-31.
20. Weiner B. An attributional theory of achievement motivation and emotion. Psychol Rev 1985; 92:548-73.
21. Wasti SP, Randall J, Simkhada P, van Teijlingen E. In what way do Nepalese cultural factors affect adherence to antiretroviral treatment in Nepal? Health Sci J 2011; 5:37-47.
22. rd ed. London: Sage Publications, 2006. 448 p.
23. Johnson RB, Onwuegbuzie AJ. Mixed methods research: a research paradigm whose time has come. Educ Res 2004; 33:14-26.
24. nd ed. Buckingham: Open University Press, 2002. 16 p.
25. Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. California, CA: Aldine Transaction, 1967. 271 p.
26. Pitchforth E, van Teijlingen E. International public health research involving interpreters: a case study from Bangladesh. BMC Public Health 2005; 5:71.
27. Van Teijlingen ER, Rennie AM, Hundley V, Graham W. The importance of conducting and reporting pilot studies: the example of the Scottish Births Survey. J Adv Nurs 2001; 34:289-95.
28. Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study. J Acquir Immune Defic Syndr 2006; 43(Suppl 1):S127-33.
29. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007; 19:658-65.
30. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003; 34:281-8.
31. Thomas D, Messerschmidt L, Messerschmidt D, Devkota B. Increasing access to essential obstetric care: a review of progress and process. Kathmandu: Nepal Safer Motherhood Project, Family Health Division, Department of Health Services, Ministry of Health, HMGN, 2004.186 p. (176/96/DFID).
32. Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health 2008; 13:904-13.
33. Alker AP, Delvaux X Mbuyi N, Ryder RW. Barriers to HIV treatment of women in Kinshasa, DRC. Paper presented on XV International AIDS Conference, Bangkok, 11-16 July 2004. Abstract no. D11201. (http://www.iasociety.org/Abstracts/ A2172260.aspx, accessed on 22 October 2012).
34. Li L, Lee SJ, Wen Y, Lin C, Wan D, Jiraphongsa C. Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand. Nurs Health Sci 2010; 12:212-20.
35. Rabkin JG, Chesney MA. Adhering to complex regimens for HIV. GMHC Treat Issues 1998; 12:8-11.
36. Murphy DA, Roberts KJ, Hoffman D, Molina A, Lu MC. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 2003; 15:217-30.
37. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2001; 26:82-92.
38. Obermeyer CM, Osborn M. The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Health 2007; 97:1762-74.
39. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 2009; 52:180-202.
40. Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002; 16:767-74.
41. Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care 2007; 19:28-33.
42. Adeneye AK, Adewole TA, Musa AZ, Onwujekwe D, Odunukwe NN, Araoyinbo ID et al. Limitations to access and use of antiretroviral therapy (ART) among HIV positive persons in Lagos, Nigeria. World Health Popul 2006; 8:46-56.
43. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS 2006; 20:359-68.
44. Kaleeba N. Excerpt from we miss you all: AIDS in the family. In: Kalipeni E, Craddock S, Oppong JR, Ghosh J, editors. HIV and AIDS in Africa: beyond epidemiology. Oxford: Blackwell, 2004:259-78.
45. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000; 19:124-33.
46. Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care 2006; 18:140-8.
47. Ka'opua L. Treatment adherence to an antiretroviral regime: the lived experience of Native Hawaiians and kokua. Pac Health Dialog 2001; 8:290-8.
48. Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Le GM. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav 2003; 7:61-72.
49. Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AK et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDS 2005; 19:526-37.
50. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004; 23:207-18.
51. Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002; 17:756-65.
52. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004; 18(Suppl 3):S27-31.